Ignite Creation Date:
2024-05-06 @ 5:49 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05441514
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2022-06-28
Brief Title:
Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-28
First Submit QC Date:
June 28 2022
Study First Post Date:
2022-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2023-12-18
Last Update Post Date Type:
ACTUAL